Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06921239

HLA Antibodies in Systemic Lupus Erythematosus

Status
Recruiting
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
Centre Hospitalier Universitaire, Amiens · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients suffering from autoimmune diseases show false-positive results when anti-HLA antibodies are identified. This false positivity makes it difficult to obtain an organ transplant based on immunological compatibility (absence of anti-HLA antibodies directed against graft antigens). The objectives of this project are to study the prevalence of these false positivities in a population of lupus patients, and to evaluate biological tests that can negate these false positivities.

Conditions

Timeline

Start date
2025-02-10
Primary completion
2026-11-01
Completion
2027-05-01
First posted
2025-04-10
Last updated
2026-01-16

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06921239. Inclusion in this directory is not an endorsement.

HLA Antibodies in Systemic Lupus Erythematosus (NCT06921239) · Clinical Trials Directory